Importantly, the study identified the Repressor Element 1 silencing transcription factor (REST) as a spatially localized marker of NE-low, immune-inflamed SCLC, correlating with enhanced antigen presentation and improved survival. The gene discussed is REST; the disease is small cell lung carcinoma.